Brachytherapy
Volume 5, Issue 1 , Pages 41-48 , January 2006

Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer

  • Marjolein Y.V. Homs

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus Medical Center/University Medical Center Rotterdam, The Netherlands
    • ,
  • Ewout W. Steyerberg

      Affiliations

    • Department of Public Health, Erasmus Medical Center/University Medical Center Rotterdam, The Netherlands
    • ,
  • Wilhelmina M.H. Eijkenboom

      Affiliations

    • Department of Radiotherapy, Erasmus Medical Center/University Medical Center Rotterdam, The Netherlands
    • ,
  • Peter D. Siersema

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus Medical Center/University Medical Center Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Gastroenterology and Hepatology, Erasmus Medical Center/University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. Tel.: +31-10-463-5946; fax: +31-10-463-4682.
    • ,
  • for the Dutch SIREC study group

Received 3 October 2005 ,Revised 8 December 2005 ,Accepted 12 December 2005.

References 

  1. Sagar PM, Gauperaa T, Sue-Ling H, et al. An audit of the treatment of cancer of the oesophagus. Gut. 1994;35:941–945
  2. De Palma GD, Galloro G, Sivero L, et al. Self-expanding metal stents for palliation of inoperable carcinoma of the esophagus and gastroesophageal junction. Am J Gastroenterol. 1995;90:2140–2142
  3. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study. Gastrointest Endosc. 2001;54:145–153
  4. Kozarek RA, Raltz S, Brugge WR, et al. Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc. 1996;44:562–567
  5. Raijman I, Siddique I, Ajani J, et al. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: Experience with 101 patients. Gastrointest Endosc. 1998;48:172–179
  6. Bartelsman JF, Bruno MJ, Jensema AJ, et al. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: Experiences in 153 patients. Gastrointest Endosc. 2000;51:134–138
  7. Spencer GM, Thorpe SM, Blackman GM, et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: A randomised study. Gut. 2002;50:224–227
  8. Dallal HJ, Smith GD, Grieve DC, et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 2001;54:549–557
  9. Taal BG, Aleman BM, Koning CC, et al. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer. 1996;74:1452–1457
  10. Schraube P, Fritz P, Wannenmacher MF. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma. Radiother Oncol. 1997;44:45–51
  11. Homs MY, Eijkenboom WM, Coen VL, et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol. 2003;66:327–332
  12. Brewster AE, Davidson SE, Makin WP, et al. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 1995;7:102–105
  13. Rowland CG, Pagliero KM. Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia. Lancet. 1985;2:981–983
  14. Kulhavy M, Sur RK, Levin CV, et al. Optimization of single-fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: A preliminary report. Endocurie Hypertherm Oncol. 1995;11:235–239
  15. Sur RK, Donde B, Levin VC, et al. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;40:447–553
  16. Sur RK, Levin CV, Donde B, et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma–an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53:127–133
  17. Sharma V, Mahantshetty U, Dinshaw KA, et al. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;52:310–315
  18. Jager J, Langendijk H, Pannebakker M, et al. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol. 1995;37:237–240
  19. Allum WH, Griffin SM, Watson A, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50:v1–v23
  20. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial. Lancet. 2004;364:1497–1504
  21. Gaspar LE, Nag S, Herskovic A, et al. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys. 1997;38:127–132
  22. Ogilvie AL, Dronfield MW, Ferguson R, et al. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23:1060–1067
  23. Sur M, Sur R, Cooper K, et al. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy. Cancer. 1996;77:2200–2205
  24. Hennequin C, Favaudon V. Biological basis for chemo-radiotherapy interactions. Eur J Cancer. 2002;38:223–230
  25. Tannock IF. Treatment of cancer with radiation and drugs. J Clin Oncol. 1996;14:3156–3174
  26. Schmidt-Ullrich RK. Molecular targets in radiation oncology. Oncogene. 2003;22:5730–5733
  27. Homs MY, Hansen BE, van Blankenstein M, et al. Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol. 2004;16:163–170

PII: S1538-4721(05)00203-5

doi: 10.1016/j.brachy.2005.12.003

Brachytherapy
Volume 5, Issue 1 , Pages 41-48 , January 2006

Article Tools

* Image Usage & Resolution